Clinical trial
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and…
NCT00224094 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00224094 |
|---|---|
| Title | A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women |
| Official title | A Comparison of Transdermal vs. Oral Estrogen Replacement Therapy on Androgen Levels and Thyroid Function in Naturally Menopausal Women |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Collaborators | Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | Premarin® (oral) vs. Alora® (transdermal) |
| Enrollment | 27 |
| Start date | Jan 1, 2002 |
| Primary completion | May 1, 2003 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: